Bio-Rad Laboratories, Inc. (BIO) Total liabilities 2016–2025
Bio-Rad Laboratories, Inc. (BIO) total liabilities at each fiscal year-end, per SEC filings.
$3.1BFY2025 · since FY2016: $1.3B → $3.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.1B | +11.7% |
| FY2024 | $2.8B | -21.4% |
| FY2023 | $3.6B | -8.5% |
| FY2022 | $3.9B | -5.5% |
| FY2021 | $4.1B | +33.0% |
| FY2020 | $3.1B | +37.2% |
| FY2019 | $2.3B | +41.7% |
| FY2018 | $1.6B | +18.5% |
| FY2017 | $1.3B | +5.6% |
| FY2016 | $1.3B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice